Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Clascoterone may be a promising treatment for hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Topical finasteride may help treat facial hirsutism in women.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Clascoterone 1% cream is a promising new treatment for acne.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Analog 23 is a promising compound for prostate cancer treatment.

Finasteride may improve prostate cancer treatment outcomes.

Dutasteride and finasteride affect different cell types differently.